EUVIMEDEUVIMED entdecken
Crossref

26-CVT-14356-ACC EVALUATION OF VUTRISIRAN IN ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY

Kristina Benbow

JACC · 2026-04 · 87 (13) · A1255

DOI: 10.1016/j.jacc.2026.02.3097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Kristina Benbow.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Benbow, K. (2026). 26-CVT-14356-ACC EVALUATION OF VUTRISIRAN IN ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY. JACC, 87(13), A1255. https://doi.org/10.1016/j.jacc.2026.02.3097

Vancouver

Benbow K. 26-CVT-14356-ACC EVALUATION OF VUTRISIRAN IN ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY. JACC. 2026;87(13):A1255. doi:10.1016/j.jacc.2026.02.3097

BibTeX
@article{Benbow2026,
  author = {Benbow, Kristina},
  title = {26-CVT-14356-ACC EVALUATION OF VUTRISIRAN IN ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {13},
  pages = {A1255},
  doi = {10.1016/j.jacc.2026.02.3097}
}
Kostenlos starten →